Related Experiment Videos
Myopathy of chronic organophosphate poisoning: a clinical entity?
Abstract:
The acute aspects of organophosphate poisoning are well understood. Persistent weakness and muscular wasting in some cases have been attributed to neuropathic effects resulting in muscular atrophy from denervation. Recently, necrosis of skeletal muscle has been induced by chronic inhibition of cholinesterase with organic phosphates in a reproducible experimental model. The literature on organophosphate poisoning in man alludes to cases in which it appears plausible to postulate this mechanism as a cause of a residual myopathy. A new case in which chronic organophosphate intoxication may be implicated in the etiology of a proximal myopathy is presented. Reports of additional cases, followed up from the onset of symptoms, are needed to determine whether primary myopathic effects are a clinically significant complication of chronic organophosphate poisoning.
Insights
Chronic organophosphate exposure may cause muscle damage, leading to a primary myopathy. Further research is needed to confirm this link in human organophosphate poisoning cases.
Area of Science:
- Toxicology
- Neurology
- Muscle Physiology
Background:
- Acute organophosphate poisoning effects are well-documented.
- Persistent weakness and muscle wasting are often linked to neuropathic damage and denervation atrophy.
- Previous research has shown skeletal muscle necrosis from chronic cholinesterase inhibition in experimental models.
Observation:
- A novel case study presents chronic organophosphate intoxication potentially causing a proximal myopathy.
- This observation aligns with existing literature suggesting a possible mechanism for residual myopathy in humans.
Findings:
- Chronic inhibition of cholinesterase by organic phosphates can induce skeletal muscle necrosis.
- A case of proximal myopathy is presented where chronic organophosphate intoxication is a potential etiological factor.
Implications:
- This study suggests primary myopathic effects may be a significant complication of chronic organophosphate poisoning.
- Further case reports and longitudinal studies are crucial to validate the role of organophosphate-induced myopathy.